Safety & Efficacy of Modified Moxibustion Therapy for Lumbar Disc Herniation .
Clinical Efficacy and Safety of a Modified Moxibustion Therapy for Low Back Pain in Lumbar Disc Herniation: A Two-Center, Randomized, Controlled, Non-Inferiority Trial.
J Pain Res . 2024 May 23:17:1853-1865.Three hundred twelve patients with low back pain due to lumbar disc herniation were randomized to receive Ma’s bamboo-based medicinal moxibustion (MBMM; n=156) or acupuncture (AT; n=156). The primary outcome of interest was the change in the Visual Analogue Scale (VAS) score on the 14th day compared to the baseline. Secondary outcomes included VAS score, Oswestry Disability Index (ODI), modified Japanese Orthopaedic Association (M-JOA) score, and serum levels of β-endorphin (β-EP) and substance-P (SP). Outcomes were assessed at baseline and on the 7th, 14th, and 28th days. Overall, the results of the study revealed no significant difference between MBMM and AT in reducing VAS scores on the 14th day. However, MBMM showed superior outcomes in ODI and M-JOA scores on the 28th day. This suggests that MBMM is a viable alternative to acupuncture for managing low back pain in lumbar disc herniation, with additional benefits in lumbar function improvement.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics